TL Genomics grants exclusive license of fetal cell diagnosis in the territory of EU
2020.07.20
TL Genomics has granted an exclusive license to a third-party company, regarding the fetal cell diagnosis patents and know-how. That company has invested in TL Genomics to collaboratively commercialize the technology.